Peter J. O’Dwyer, MD
Group Co-Chair

Dr. O’Dwyer is the group co-chair of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN), overseeing governance and scientific initiatives. A medical oncologist with expertise in gastrointestinal and pancreatic cancers, Dr. O'Dwyer is a physician at Penn Medicine and a professor of medicine at the University of Pennsylvania in Philadelphia. He is the CEO and chair of the PrECOG, LLC Board of Managers and president of both the ECOG-ACRIN Medical Research Foundation and ECOG Research and Education Foundation.

Dr. O’Dwyer’s research focuses on the development of novel therapies, primarily for pancreatic and colorectal cancers. He previously led the Developmental Therapeutics Programs at Fox Chase Cancer Center and the University of Pennsylvania, chaired the ECOG-ACRIN Gastrointestinal Cancer Committee, and founded ECOG-ACRIN's Developmental Therapeutics Committee. He has more than 350 scientific papers in medical literature and participates in numerous national and international organizations. He co-chaired the landmark NCI-MATCH precision medicine cancer trial.